Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms and soles. These plaques can crack open ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

People with plaque psoriasis may not always have symptoms. Some may experience intense itching, especially with plaques on the scalp. Soreness and pain may also occur on the palms of the hands and ...

The primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin.

6 Clinicaltrials.gov. A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles of the feet ...

NCT06095102), which evaluated icotrokinra in patients with plaque psoriasis affecting special areas (scalp, genital, and palms of the hands and soles of the feet) were also announced. Results ...

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with investigational icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD Topline ...

and/or hands and feet) with overall IGA score of 0 or 1 with at least a 2-grade improvement as the primary endpoint.6 About Plaque PsoriasisPlaque psoriasis (PsO) is a chronic immune-mediated ...

ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% ...